Treatment With SU11248 in Patients With Neuroendocrine Tumors

Clinical trial NCT00056693 · COMPLETED

Trial details

NCT number: NCT00056693
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2003-04-01
Primary completion: 2006-09-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.